Suppr超能文献

高血压和其他慢性病药物的处方和配药期限:审查国际政策和证据以为澳大利亚的情况提供信息。

Prescription and dispensing duration of medicines for hypertension and other chronic conditions: a review of international policies and evidence to inform the Australian setting.

机构信息

Department of Health, Medicine and Caring Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.

The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.

出版信息

Hypertens Res. 2024 Aug;47(8):2104-2114. doi: 10.1038/s41440-024-01743-2. Epub 2024 Jun 7.

Abstract

The duration of treatment for which a physician may prescribe a medicine, 'prescription duration', is often dispensed at the pharmacy on multiple occasions of shorter time periods, 'dispensing duration'. These durations vary significantly between and within countries. In Australia, the quantity of medication supplied at each dispensing has recently been extended from 30 to 60 days for a selection of medicines used for chronic health conditions, such as diabetes and hypertension. Dispensing durations vary between countries, with 30, 60 or 90 days being the most common-with 90 days aligning with the recommendation of the 2023 Global Report on Hypertension from the World Health Organization. The full impact of shorter vs longer prescription durations on health costs and outcomes is unknown, but current evidence suggests that 90-day dispensing could reduce costs and improve patient convenience and adherence. More rigorous research is needed.

摘要

医生可以开的药的治疗时长,即“处方时长”,通常会在多次较短的时间内在药店配药,即“配药时长”。这些时长在不同国家和同一国家内都有很大差异。在澳大利亚,为了治疗一些慢性疾病,如糖尿病和高血压,最近将每次配药的药物供应量从 30 天延长到 60 天。各国的配药时长不同,最常见的是 30、60 或 90 天,而 90 天与世界卫生组织 2023 年全球高血压报告的建议一致。较短和较长的处方时长对健康成本和结果的全面影响尚不清楚,但现有证据表明,90 天配药可以降低成本,提高患者的便利性和依从性。需要进行更严格的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc1/11298406/5563afa24727/41440_2024_1743_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验